Investor Alert: Class Action Lawsuits Targeting BioVie and ADM Among Others

NEW YORK, March 09, 2024 – Shareholders are being alerted to the initiation of class action lawsuits by the law firm Bragar Eagel & Squire, P.C., which is recognized for its commitment to representing stockholder rights. The firm has announced the commencement of lawsuits on behalf of investors in various companies, including BioVie Inc. BIVI and Archer-Daniels-Midland Company ADM.

Background on BioVie Inc. BIVI

BioVie Inc. BIVI, operating out of Santa Monica, California, is a clinical-stage biotechnology enterprise. It focuses on the invention, advancement, and commercialization of therapeutic drugs within the United States. The research and development efforts of BioVie are integral to the biotech industry, with an aim to bring innovative treatments to market, enhancing patient healthcare outcomes.

About Archer-Daniels-Midland Company ADM

The Archer-Daniels-Midland Company ADM, known as ADM, is a global force in food processing and commodities trading. Founded in 1902 and anchored in Chicago, Illinois, ADM has a vast network of over 270 processing plants and 420 crop acquisition facilities across the globe. Cereal grains and oilseeds refined by ADM serve a diverse spectrum of markets, including food, beverage, nutraceuticals, industry, and animal nutrition.

Investors who purchased stocks in these companies may now be eligible to participate in the lawsuits and are encouraged to contact Bragar Eagel & Squire, P.C. to ensure their rights are protected. By taking action, stockholders are asserting their stance in what could become pivotal legal disputes in the economic landscape.

Investor, Lawsuit, BioVie, ADM